Company profile: Artizan Biosciences
1.1 - Company Overview
Company description
- Provider of drug discovery and development focused on diseases involving the human intestinal microbiota.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Artizan Biosciences
Recursion
HQ: United States
Website
- Description: Provider of a machine learning-driven drug discovery platform (Recursion OS), digital chemistry tools (MatchMaker), and an on-premise supercomputer (BioHive-1) to map complex biology and rapidly advance potential therapeutics; also collaborates with Bayer, Roche & Genentech, NVIDIA, Tempus, and Enamine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Recursion company profile →
Arena Pharmaceuticals
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical research and development focused on cardiovascular, central nervous system, inflammatory, and metabolic diseases, including the development of lorcaserin hydrochloride, which has reported positive clinical trial data. Headquartered in San Diego, CA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arena Pharmaceuticals company profile →
Imbria
HQ: United States
Website
- Description: Provider of clinical-stage cardiometabolic therapies centered on ninerafaxstat, an investigational cardiac mitotrope designed to enhance cellular energy metabolism by increasing energy per molecule of oxygen consumed. Conducts Phase 2 trials: IMPROVE-HCM (non-obstructive HCM), IMPROVE-ISCHEMIA (stable angina/chronic coronary syndrome), and IMPROVE-DiCE (type 2 diabetes with HFpEF).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Imbria company profile →
Animol Discovery
HQ: United States
Website
- Description: Provider of a drug discovery platform combining DNA-encoded chemical libraries, AI/ML, and computational chemistry to rapidly identify novel veterinary medicines; focuses on discovering and developing small-molecule drugs for companion and farm animals addressing infectious and chronic diseases, with a proprietary pipeline of veterinary small molecules including next-generation antiparasitics and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Animol Discovery company profile →
Pin Therapeutics
HQ: South Korea
Website
- Description: Provider of advanced protein degradation therapeutics, utilizing biological pathways of proteostasis to develop therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pin Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Artizan Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Artizan Biosciences
2.2 - Growth funds investing in similar companies to Artizan Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Artizan Biosciences
4.2 - Public trading comparable groups for Artizan Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →